Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
ProMIS Neurosciences | PMN | Nov 26, 2024 | 0.92 | 0.00 |
PropertyGuru | PGRU | Nov 26, 2024 | 6.65 | +0.15 |
ProPetro | PUMP | Nov 26, 2024 | 8.41 | -0.47 |
ProPhase Labs | PRPH | Nov 26, 2024 | 0.75 | +0.60 |
ProQR Therapeutics | PRQR | Nov 26, 2024 | 3.44 | -2.82 |
PROS | PRO | Nov 26, 2024 | 23.00 | -4.37 |
ProShares Bitcoin Strategy ETF | BITO | Nov 26, 2024 | 24.40 | -4.24 |
Proshares Ultra FTSE Europe | UPV | Nov 26, 2024 | 56.65 | -1.14 |
ProShares UltraShort Bloomberg Natural Gas | KOLD | Nov 26, 2024 | 55.16 | -3.53 |
Proshares Ultrashort FTSE Europe | EPV | Nov 26, 2024 | 41.44 | +2.73 |
Prospect Capital | PSEC | Nov 26, 2024 | 4.74 | -1.46 |
Prospect Capital A Pref | PSEC-A | Nov 26, 2024 | 19.31 | -0.08 |
Prosperity Bancshares | PB | Nov 26, 2024 | 84.73 | -0.40 |
Protagenic Therapeutics | PTIX | Nov 26, 2024 | 0.73 | +13.00 |
Protagonist Therapeutics | PTGX | Nov 26, 2024 | 44.83 | -1.54 |
Protalix Bio Therapeutics | PLX | Nov 26, 2024 | 1.68 | -1.75 |
Protara Therapeutics | TARA | Nov 26, 2024 | 2.94 | +13.08 |
Prothena | PRTA | Nov 26, 2024 | 15.58 | +3.32 |
Proto Labs | PRLB | Nov 26, 2024 | 41.11 | -0.02 |
Provident Bancorp | PVBC | Nov 26, 2024 | 11.58 | 0.00 |
Provident Financial | PROV | Nov 26, 2024 | 16.02 | +0.75 |
Provident Financial Services | PFS | Nov 26, 2024 | 21.29 | -1.71 |
Prudential ADR | PUK | Nov 26, 2024 | 16.10 | -1.65 |
Prudential Financial | PRU | Nov 26, 2024 | 129.11 | +0.31 |
Ps International Group | PSIG | Nov 26, 2024 | 0.55 | -1.79 |
PSQ Holdings | PSQH | Nov 26, 2024 | 2.02 | -3.81 |
Psychemedics | PMD | Nov 26, 2024 | 2.34 | 0.00 |
Psyence Biomedical | PBM | Nov 26, 2024 | 3.34 | +6 872.86 |
PT Telkom Indonesia (Persero) Tbk ADR | TLK | Nov 26, 2024 | 16.84 | -1.92 |
PTC | PTC | Nov 26, 2024 | 199.26 | -0.66 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.